Display Settings:

Format

Send to:

Choose Destination
    J Clin Pathol. 2003 Mar;56(3):182-7.

    Bacillus anthracis.

    Source

    Public Health Laboratory, Bristol Royal Infirmary, UK. robert.spencer@ubht.swest.nhs.uk

    Abstract

    The events of 11 September 2001 and the subsequent anthrax outbreaks have shown that the West needs to be prepared for an increasing number of terrorist attacks, which may include the use of biological warfare. Bacillus anthracis has long been considered a potential biological warfare agent, and this review will discuss the history of its use as such. It will also cover the biology of this organism and the clinical features of the three disease forms that it can produce: cutaneous, gastrointestinal, and inhalation anthrax. In addition, treatment and vaccination strategies will be reviewed.

    PMID:
    12610093
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1769905
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk